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     Streptococcus pneumoniae (the 
pneumococcus) is a noteworthy pathogen 
worldwide and provokes infectious 
maladies such as pneumonia, septicemia, 
and meningitis [3,4]. World Health 
Organization (WHO) has evaluated that 
476000 yearly passing among youngsters 
under 5 years old are caused by 
pneumococcal diseases [5]. Antibiotic 
treatment of pneumococcal disease is being  
 
compromised by emerging multidrug 
resistant strains [6,9]. The pneumococcal 
capsule has been perceived as its primary 
factor of virulence, comprising of a 
biopolymer of rehashed oligosaccharides 
[10,12] . Each pneumococcal serotype 
corresponds to a different chemical 
structure of the capsule. S. pneumoniae 
serotypes containing 1, 5, 6A, 6B, 14, 19F, 
and 23F is the main reason of most invasive 
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Abstract   
Introduction:  Capsular polysaccharides of pneumococci are principle 
antigenic constituents of vaccines against pneumococci. Enhancing the yield of 
capsule production decreases costs of these vaccines and increases the vaccine 
coverage in developing countries. This study aims to optimize the capsule 
production from serotype 19F pneumococcus in terms of the applied 
pneumococcal strain and environmental culture conditions.  
Materials and Methods:  Thirteen serotype 19F Streptococcus pneumoniae 
strains were screened for the capsule production in modified Hoeprich culture 
medium using the stains all assay. The optimal ranges of environmental culture 
conditions for the selected strain were determined using single factor at a time 
(SFAT) strategy and utilized for the design of experiments based on the 
response surface methodology (RSM).  
Results:  S. pneumoniae 82218 showed the highest capsule production, and 
thus used for further studies. The maximum capsule production (1.364 mg/ml) 
was attained under optimal conditions (pH 7.26, 35.5 ºC, 30 rpm) predicted by 
the RSM derived quadratic model. The capsule production under the optimal 
conditions increased to 1.9 mg/ml using the buffered culture medium. 
Conclusion:  These results are much higher than those reported for 
pneumococcal capsule production in published studies [1, 2] and thus can be 
used to design suitable systems for the serotype 19F capsule production in the 
vaccine manufacturing process.   
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pneumococcal infections in kids under 5 
years old globally [13].  
Pneumococcal capsules are main antigenic 
components of pneumococcal vaccines,  
which have been utilized for prevention 
of pneumococcal diseases. However, the 
capsular immunizations are ineffectively 
immunogenic in youthful kids and cannot 
prompt anamnestic immune responses upon 
revaccination. The capsule is therefore, 
changed from a T-cell free antigen to a T-
cell activating antigen via conjugation to an 
immunogenic carrier protein. As a result, 
the antibody response is enhanced and the 
immunological memory is elicited. The 
manufacturing of pneumococcal conjugate 
vaccines (PCVs) requires bioprocesses 
containing several steps and is costly. WHO 
advises to incorporate PCVs in national 
vaccination programs for kids, whereas 
high production expenses of these vaccines 
restricts their usage in developing nations 
[3,5,13]. Production costs of microbial 
compounds are diminished through 
enhancing the production yield through 
optimizing conditions of microbial 
cultivation [14,15]. Nonetheless, few 
investigations have been reported on 
improving cultivation conditions of S. 
pneumoniae for increasing capsule 
production. The importance of selecting an 
appropriate S. pneumoniae strain for 
enhancing the serotype 14 pneumococcal 
capsule production was demonstrated in 
the present study [16]. The production of 
capsular polysaccharide by the serotype 4 
pneumococcus was observed to be 
dependent on the culture medium pH [1]. 
Moreover, the serotype 3 pneumococcal 
capsule productivity increased in agitated 
cultures. However, the capsule production 
decreased at agitation rates exceeding 180 
rpm which was attributed to the damaging 
effect of elevated shear stress on 
pneumococcal cells [17]. Cimini et al. 
investigated the influence of temperature 
on the capsular polysaccharide production 
by Escherichia coli K4. Their results 
demonstrated that the capsule production 
got enhanced at higher temperatures [18].  
Response surface methodology (RSM) has 
been a popular and efficient statistical 
technique that has been widely used for 
optimization studies in biotechnological 
processes. It can be used for designing 
experiments, constructing accurate 
mathematical models to describe the 
process, assessing the effects of factors 
alone or in combination on the response, 
and specifying optimum conditions of 
factors to obtain desirable responses [17, 
19]. Based on the authors’ current 
knowledge, there are no reports assessing 
and optimizing impacts of bacterial strains 
and environmental culture conditions for the 
capsule production by serotype 19F S. 
pneumoniae as one of the main serotypes 
leading to most invasive pneumococcal 
infections in kids under 5 years of age.  
Therefore, in the current study, a suitable 
pneumococcal strain was determined as 
well as appropriate ranges of environmental 
culture conditions including temperature, 
pH and agitation rate for the serotype 19F 
capsule production using single factor at a 
time (SFAT) method. Then, RSM based on 
the SFAT results was used to obtain an 
optimized culture method for the capsular 
polysaccharide preparation.  
 
2. Materials and Methods 
2.1 Microorganisms and Stock Cultures                                                                                    
     This study was a basic research in the 
field of biotechnology and was approved by 
the research ethics committee of Shahid 
Beheshti University of Medical Sciences 
under the code: SBMU.REC.1392.494. Six 
clinically isolated strains of S. pneumoniae 
including 62P, 64P, 65P, 70P, 87P, and 
BbP were supplied by Pediatric Infections 
Research Center (PIRC) (Tehran, Iran). 
Four other clinical strains of S. pneumoniae 
including 67H, 101H, 80H and 110H were 
provided by Health Reference Laboratories 
Research Center (Tehran, Iran). S. 
pneumoniae ATCC 6319 (American Type  
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Culture Collection, Rockville, MD, USA), 
S. pneumoniae ATCC 49619, and S. 
pneumoniae 82218 (Statens Serum 
Institute, Copenhagen, Denmark) were also 
used in this study. Pneumococcal strains were 
propagated in tryptic soy broth (TSB) 
including 5% defibrinated sheep blood 
u n de r  5% CO2 at 37 °C for 18 h and 
kept up at -70 °C in a similar medium 
containing 20% (v/v) glycerol [20]. 
 
2.2 Cultivation Conditions                                                                                                                                 
     S. pneumoniae strains were cultivated 
using Hoeprich’s modified medium 
(HMM). This medium composed of glucose 
(20g/l), hydrolyzed soybean meal (soytone) 
(20 g/l), yeast extract (20g/l), s o d i u m 
b i ca r b o n a t e  ( 1  g / l ) ,  D i p o t a s s i um 
h yd r o gen  p h o s p h a t e  ( 5 g/l), 
asparagine (100 mg/l), L-glutamine (624 
mg/l), manganese (II) sulfate (0.36 mg/l), 
Iron (II) sulfate (5 mg/l), magnesium sulfate 
(500 mg/l), zinc sulfate (0.8 mg/l), choline 
(10 mg/l), and 10% (v/v) thioglycolic acid 
(0.1% v/v). The culture medium pH was 
set to 7.5 and sterile filters (0.22 µm) were 
applied to sterilize the broth.  Glucose, 
soytone and yeast extract were products of 
BD-Difco (Sparks, USA). All other 
compounds were from Sigma-Aldrich 
(Saint Louis, USA). Potassium phosphate 
buffer (0.1M) at appropriate pH was used to 
dissolve HMM constituents rather than 
distilled water when buffering was required. 
Tryptic soy agar (TSA) p l a t e s  
supplemented with defibrinated sheep 
blood (5%) were inoculated by frozen stock 
cultures of S. pneumoniae strains. The 
incubation of the plates was done under 
CO2 (5%). After incubating the plates for 
18h at 37 ºC, The optical density at 600 nm 
(OD600) of HMM was adjusted to 0.15 by 
transferring plate colonies. The obtained 
broth was utilized for inoculating HMM 
(10% (v/v)) in 50 ml bottles, which were 
kept 18 h at 37 °C with tight lids at desired 
agitation speed [2, 20]. 
 
 
2.3 Capsule Measurement 
     Stains all assay was used to quantify the 
capsule production. Briefly, S.pneumoniae 
cells were harvested by centrifugation and 
suspended in a buffer containing 
magnesium sulfate (1mM) and tris-
hydrochloric acid (150 mM, pH 7.0) to 
obtain a final OD600 of 5. One ml of the 
suspension was centrifuged to separate the 
cells from the supernatant. The cells were 
then suspended in the buffer (0.5 ml). The 
autolysis of bacteria was prompted by
adding deoxycholate to the cell suspension 
to a final concentration of 0.1% wt/vol 
followed by incubating for 15 min at 37 °C. 
Ribonuclease A (50 µg), deoxyribonuclease 
I (50 µg), and mutanolysin (100 U) were 
added to the pneumococcal cells and the 
incubation was further continued for 18 h. 
The supernatant was treated similar to the 
cells without using mutanolysin. 
Proteinase K (50 µg) was added to the 
samples, which were kept for 4h at 56 °C 
and then stored at -20 °C. Two hundred 
microliters of water and 1 ml of stains-all 
solution were added to 50 µl of the cellular 
samples and OD640 was measured. The 
supernatant samples (250 µl) were also 
mixed with stains-all solution (1 ml) prior 
to reading OD640. A standard calibration 
graph correlating values of OD640 to the 
concentration of S. pneumoniae serotype 
19F capsule (Statens Serum Institute, 
Copenhagen, Denmark) was used for the 
capsule quantification. The sum of the 
cellular capsule and the capsule in the 
supernatant was used to report capsule 
production values in the culture [21]. 
 
2.4 Experimental Design, Statistical 
Analysis and Modeling by RSM 
     The appropriate bacterial strain for 
serotype 19F pneumococcal capsule 
production was selected via measuring the 
capsule production following cultivation in 
HMM. The statistical significance of results  
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was analyzed using Tukey test of SPSS 
software (IBM Corp, NewYork, USA). 
Specifying suitable ranges of environmental 
culture conditions including pH, 
temperature, and agitation speed for the 
selected bacterial strain was carried out 
using SFAT method. Experiments were 
performed in duplicate and the average 
values for the capsule production and 
standard deviations were reported. RSM 
was then designed to optimize the 
environmental culture conditions for 
producing capsule at maximum level. 
Design Expert Software (Statease, 
Minneapolis, USA) was used to provide the 
RSM face centered central composite 
design resulting in 20 experiments. The 
variables were evaluated at three levels (-1, 
0, +1) as indicated in Table 1. The tests 
were carried out in duplicate and the 
average values for the capsule production 
and standard deviations were reported. A 
polynomial equation was used to fit the 
obtained results using the response surface 
regression procedure. Statistical parameters 
were determined using Analysis of variance 
(ANOVA). ANOVA is based on 
decomposition of the total variability of the 
response to two sources including the 
experimental error and the model to 
demonstrate whether the variation from the 
model is significant compared to the 
variation due to the experimental error. This 
comparison is done using Fisher’s F-test 
value, which is the ratio between the model 
and the error mean squares. Fisher's test was 
therefore applied to assess the equation of 
the model and its components in terms of 
statistical significance. The determination 
coefficient (R
2
) was used to examine the 
model fit quality. Three dimensional surface 
plots of the model equation were used to 
demonstrate the correlation between the 
response and variables. The verification 
experiment was performed under optimal 
conditions predicted by the model for 
capsule production. P-values less than 0.05 
are considered as statistically significant 
[17, 19]. 
2.5 Protein Profile Analysis of 
Pneumococcal Strains  
     Pneumococcal cells cultivated in HMM 
(2.5 OD600) were collected by centrifugation 
and washed once with phosphate buffered 
saline. The bacterial pellet was then 
suspended in the same buffer containing 
0.1% sodium deoxycholate and incubated 
for 1h at 37 ºC. For analysis of the samples, 
SDS-PAGE (10%) was used and the gel 
was stained using Coomassie Brilliant Blue 
R250 [22].  
 
3. RESULTS 
3.1 Screening of Pneumococcal Strains 
for Serotype 19F Capsule Production 
     The pneumococcal capsule is a cell 
surface exposed structure of polysaccharide 
nature, which is firmly connected with the 
capacity of pneumococci to induce invasive 
diseases [10]. The serotype 19F S. 
pneumoniae strains were examined in terms 
of capsule production following cultivation 
in HMM, which is an animal component 
free medium and is acceptable for the 
vaccine production. The maximum capsule 
production was observed for S. pneumoniae 
67H among the clinical strains (Table 1). 
However, the capsule production by S. 
pneumoniae 82218 (1.053 mg/ml) was 1.6 
fold higher than that of the obtained one, 
using S. pneumoniae 67H and the observed 
difference was statistically significant. 
Therefore, S. pneumoniae 82218 was 
selected as the appropriate strain for the 
serotype 19F capsule production and used 
in further studies to evaluate and optimize 
environmental culture conditions for the 
capsule production. The analysis of the 
bacterial protein profile using SDS-PAGE 
indicated the difference between the 
intensity of two protein bands in the range 
of 99-100 kDa in S. pneumoniae 82218 and 
S. pneumoniae 67H (Figure. 1). Therefore, 
these proteins were expressed differentially 
in the two studied pneumococcal strains. 
Therefore, these proteins were expressed 
differentially in the two studied 
pneumococcal strains. The results indicated 
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that expression levels of these proteins may 
affect the capsule production level. The 
pneumococcal genetic locus encoding the 
genes involved in the capsule formation 
(cps locus) constitutes an operon 
transcribing from a promoter in its upstream 
region. The regulatory and processing genes 
of the cps locus including cpsA, cpsB, cpsC, 
and cpsD are highly conserved among 
different pneumococcal serotypes. Other 
genes of the cps locus are required to 
encode necessary enzymes for production 
and export of the capsule of each 
pneumococcal serotype [10, 23]. The fifth 
gene of the cps locus (cpsE) encodes a 
glucose phosphate transferase enzyme, 
which catalyzes the transfer of the activated 
glucose phosphate to the lipid carrier. The 
capsule expression in S. pneumoniae was 
lost as a result of mutation of the cpsE gene 
[24]. In addition, Carvalho et al. 
demonstrated that inactivation of the 
pyruvate oxidase encoding gene in S. 
pneumoniae resulted in enhanced capsule 
production [25]. These studies together with 
the present study’s results demonstrated that 
the identification of proteins affecting the 
pneumococcal capsule production paves the 
way for constructing appropriate 




Table 1. Serotype 19F capsule production by 
pneumococcal strains 
Capsule production (mg/ml) Pneumococcal strain 
0,813 ± 0,043 S. pneumoniae ATCC 6319 
0,343 ± 0,048 S. pneumoniae ATCC 49619 
1,053 ± 0,010 S. pneumoniae 82218 
0,370 ± 0,054 S. pneumoniae 62P 
0,458 ± 0,037 S. pneumoniae 64P 
0,514 ± 0,010 S. pneumoniae 65P 
0,435 ± 0,030 S. pneumoniae 70P 
0,540 ± 0,011 S. pneumoniae 87P 
0,336 ± 0,026 S. pneumoniae BbP 
0,656 ± 0,010 S. pneumoniae 67H 
0,610 ± 0,032 S. pneumoniae 101H 
0,387 ± 0,044 S. pneumoniae 80H 




Figure 1. Analysis of protein profiles of pneumococcal 
strains. Lane 1, S. pneumoniae 67H; lane 2, S. pneumoniae 
82218; lane M, molecular weight marker 
 
3.2 Determining Optimal Ranges of 
Environmental Culture Conditions for 
Capsule Production Using SFAT 
Method  
Several single factor experiments were 
carried out to determine appropriate ranges 
of environmental culture conditions for the 
capsule production using S. pneumoniae 
82218. The tested variables included pH, 
temperature, and agitation speed. To 
determine the effect of pH on the serotype 
19F capsule production, HMM was used in 
5 different initial pH levels (from pH 6 to 
pH 8) for the cultivation of S. pneumoniae 
82218. The bacterial growth enhanced with 
increasing pH (from pH 6 to pH 7.5) as 
measured by OD600. OD600 in pH 8 was 
similar to that in pH 7.5 (Figure. 2a). The 
capsule production was best achieved in pH 
6.5 to pH 7.5 and it was notably decreased 
in pH 6 and pH 8. The capsule production 
in pH 7.5 was 1.8 fold higher than that in 
pH 8.0 in spite of the similar OD600 for the 
bacterial growth.  
To examine the influence of cultivation 
temperature, S. pneumoniae 82218 cells 
were cultivated in HMM and incubated at 
34 ºC – 39 ºC. The capsule production at 
37ºC was 2.35 fold higher than that at 34 ºC 
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(Figure. 2b). Moreover, the suitable 
temperature range for the capsule 
production was around 36ºC to 37ºC. It was 
further studied at different agitation speeds 
and was highest at agitation rates of 0-30 
rpm. However, the capsule production was 
notably decreased at agitation rates of 50 
rpm or higher. No bacterial growth was 
observed at 90 rpm or higher agitation rates 
(Figure. 2c). It was shown that the serotype 
4 pneumococcal capsule production was 
inhibited by vigorous agitation (higher than 
100 rpm) but was enhanced at the agitation 
rate of 50 rpm [1]. In addition, the serotype 
3 pneumococcal capsule production was 
decreased at agitation rates exceeding 180 
rpm [17]. These results were attributed to 
the elevated shear stress at higher agitation 







Figure 2a. The effect of pH on capsule production by S. pneumoniae 82218 and the bacterial growth obtained using SFAT. Bar 
lines and triangles indicate the capsule production and bacterial growth respectively 
 
 
Figure 2b. The effect of temperature on capsule production by S. pneumoniae 82218 and the bacterial growth obtained using 
SFAT. Bar lines and triangles indicate the capsule production and bacterial growth respectively 
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Figure 2c. The effect of agitation rate on capsule production by S. pneumoniae 82218 and the bacterial growth obtained using 
SFAT. Bar lines and triangles indicate the capsule production and bacterial growth respectively 
 
3.3 Optimization of Capsule Production 
Using RSM   
Using RSM for experimental design offers 
a number of advantages including 
evaluation of factor effects, development of 
a system model, as well as specifying 
optimal conditions with less experimental 
requirements [17,19]. Considering the 
suitable ranges of environmental factors for 
the capsule production obtained using 
SFAT experiments, the RSM experimental 
design was applied to determine the 
optimum conditions of environmental 
factors (Table 2). This study’s results 
displayed that the highest capsule 
production (1.349 mg/ml) was obtained in 
run 6, while the lowest value (0.294 mg/ml) 
was attained in run 8. A quadratic 
polynomial equation demonstrated the 
correlation between capsule production and 
environmental conditions of the 
pneumococcal culture. The equation 
parameters were specified by multiple 
regression analysis of results of the 
experiments. The obtained quadratic 
polynomial model describing the empirical 
relationship between the response and 
variables is as follows: 
Y = 0.8 + 0.11A – 0.21 B – 0.14 C – 0.12 





 + 0.28 C
2 
where the equation 
response (Y) is the capsule production 
(mg/ml), A is pH, B is temperature (ºC), 
and C is agitation speed (rpm). ANOVA of 
the response surface quadratic model is 
demonstrated in Table 3. The adequacy of 
the model equation was examined using 
Fisher’s statistical test. The F-value of the 
model (37.03) and its p-value (< 0.0001) 
indicated the significance of the model and 
that the chance of the model F-value to 
happen by noise was just 0.01% [23]. A, B, 




 were significant 
model terms (p values < 0.05). The lack of 
fit was not significant and therefore, the 
model fitted the experimental data properly. 
A high R
2
 value (0.9709) also ensured the 
model adequate fitness with the data and 
showed that 97.09% of the variation in the 
capsule production could be described by 
the model. The value of adequate precision 
specifies the signal to noise ratio, which is 
more than 4 for suitable models. The 
adequate precision value for producing the 
capsule was 22.276. This result implied a 
proper signal for the model [23]. The 
suitability of size of RSM design was 
evaluated using “Fraction of Design Space 
(FDS)” generated by Design expert 
software. An FDS value above 80% 
suffices for generating a precise fitted 
surface model. As for the case of the 
present study, an FDS value of 94% 
(standard deviation of 0.06 and half wide of 
the confidence interval of 0.1 for the 
optimal response) far exceeds 80% and 
indicated that 94% of the design space was 
precise enough to predict the optimal 
response ± 0.1[24,25]. 
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Three dimensional response surface plots 
were graphical representations of the model 
equation and showed the correlation 
between the capsule production and levels 
of pH, temperature, and agitation rate 
(Figure. 3a, b). The maximum capsule 
production (1.352 mg/ml) predicted by the 
model was expected to attain at pH 7.26, 
35.5 ºC and 30 rpm. The verification 
experiment was then carried out using the 
predicted optimum environmental culture 
conditions for the cultivation of S. 
pneumoniae. The capsule production under 
these conditions was 1.364 mg/ml, which 
was not significantly different from the 
predicted value (Table 4). This result 
therefore indicated the validity and 






   Table 2. RSM based experimental design for capsule production and responses 
Run pH  (A)* Temperature (B) Agitation rate (C) capsule production (mg/ml) 
1 6.5 (-1) 35.5 (-1) 0 (-1) 0.859 ± 0.00141 
2 7.5 (+1) 35.5 (-1) 0 (-1) 1.289±0.002051 
3 6.5 (-1) 37.5 (+1) 0 (-1) 0.923±0.003323 
4 7.5 (+1) 37.5 (+1) 0 (-1) 1.039±0.01202 
5 6.5 (-1) 35.5 (-1) 30 (+1) 0.89±0.03041 
6 7.5 (+1) 35.5 (-1) 30 (+1) 1.349±0.01003 
7 6.5 (-1) 37.5 (+1) 30 (+1) 0.457±0.00071 
8 7.5 (+1) 37.5 (+1) 30 (+1) 0.294±0.02263 
9 6.5 (-1) 36.5 (0) 15 (0) 0.524±0.01061 
10 7.5 (+1) 36.5 (0) 15 (0) 0.754±0.05162 
11 7 (0) 35.5 (-1) 15 (0) 1.013±0.01732 
12 7 (0) 37.5 (+1) 15 (0) 0.632±0.03182 
13 7 (0) 36.5 (0) 0 (-1) 1.254±0.00566 
14 7 (0) 36.5 (0) 30 (+1) 0.952±0.09051 
15 7 (0) 36.5 (0) 15 (0) 0.765±0.05940 
16 7 (0) 36.5 (0) 15 (0) 0.795±0.07495 
17 7 (0) 36.5 (0) 15 (0) 0.842±0.02899 
18 7 (0) 36.5 (0) 15 (0) 0.806±0.04667 
19 7 (0) 36.5 (0) 15 (0) 0.811±0.01131 
20 7 (0) 36.5 (0) 15 (0) 0.658±0.01556 
* Coded values of variables are indicated in parentheses. 
 
Table 3. ANOVA for RSM model of capsule production 
Source Sum of Squares F - Value p - Value 
Model 1.32 37.03 < 0.0001 
A, pH 0.11 28.98 0.0003 
B, Temperature 0.42 106.49 < 0.0001 
C, Agitation rate 0.2 50.99 < 0.0001 
AB 0.11 27.62 0.0004 
AC 7.812E-003 1.97 0.1907 
BC 0.21 53.44 < 0.0001 
A2 0.093 23.33 0.0007 
B2 2.273E-008 5.731E-006 0.9981 
C2 0.22 54.60 < 0.0001 
Lack of Fit 0.019 0.91 0.5421 
pH, temperature and agitation rate were independent variables. The capsule production was dependent variable. R2 = 0.9709 and 
adequate precision 22.276. Adequate precision denotes signal to noise ratio and it should be more than 4 for appropriate models.  
 
 
Table 4. The capsule production under RSM predicted optimal conditions and using buffered HMM 
Cultivation conditions Capsule production (mg/ml) OD600 Final pH 
*pH 7.26, 35.5 ºC and 30 rpm 1.364 ± 0.048 3.285 ± 0.12 4.93 ± 0.01 
pH 7.26, 35.5 ºC and 30 rpm  and 
using buffered HMM      
1.9 ± 0.019 5.3 ± 0.1 6.1± 0.05 
*RSM predicted optimal conditions for 19F capsule production. 
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C: Agitation rate 
 
Figure 3b. The response surface plot for capsule production indicating effects of temperature and agitation rate 
 
 
3.4 Capsule Production in Buffered 
Medium 
     S. pneumoniae is among lactic acid 
bacteria (LAB). The primary product of 
LAB is lactic acid, which can decrease the 
culture pH [26]. The primary product of 
LAB is lactic acid, which can decrease the 
culture pH [31] . S. pneumoniae 82218 was 
cultivated in buffered HMM under optimal 
environmental conditions obtained from 
RSM. The decrease in pH of buffered 
HMM was lower than that of HMM 
following cultivation of S. pneumoniae 
82218 (Table 4). The bacterial growth was 
notably increased in the buffered HMM as 
indicated by OD600. Moreover, the capsule 
production increased 1.39 fold through 
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buffering HMM. However, preparation of 




     In this research, S. pneumoniae 82218 
was identified as the most suitable strain 
for 19F capsule production because it 
showed the highest level of the 19F 
polysaccharide production among the 
studied pneumococcal strains. The 
observed difference in the protein 
electrophoretic profile of S. pneumoniae 
82218 and that of S. pneumoniae 67H 
indicated that expression levels of the 
identified proteins may affect the capsule 
production level. The pneumococcal genetic 
locus encoding the genes involved in the 
capsule formation (cps locus) constitutes an 
operon transcribing from a promoter in its 
upstream region. The regulatory and 
processing genes of the cps locus including 
cpsA, cpsB, cpsC, and cpsD are highly 
conserved among different pneumococcal 
serotypes. Other genes of the cps locus are 
required to encode necessary enzymes for 
production and export of the capsule of each 
pneumococcal serotype [10, 27]. The fifth 
gene of the cps locus (cpsE) encodes a 
glucose phosphate transferase enzyme, 
which catalyzes the transfer of the activated 
glucose phosphate to the lipid carrier. The 
capsule expression in S. pneumoniae was 
lost as a result of mutation of the cpsE gene 
[28]. In addition, Carvalho et al. 
demonstrated that inactivation of the 
pyruvate oxidase encoding gene in S. 
pneumoniae resulted in enhanced capsule 
production [29]. These studies together with 
the present study results demonstrated that 
the identification of proteins affecting the 
pneumococcal capsule production paves the 
way to construct appropriate pneumococcal 
strains for the vaccine manufacture.  
Rault et al. showed that the intracellular pH 
of Lactobacillus delbrueckii decreased 
concomitantly with the extracellular pH 
decrease. The intracellular pH is a key 
factor influencing several cellular processes 
including proton motive force, transport 
kinetics, ATP generation, and enzyme 
activities [30]. Therefore, the present 
results can be attributed to the pH effect on 
activities of enzymes involved in the 
capsule biosynthesis in pneumococcal cells. 
These results also demonstrated that the 
19F capsule production as well as the 
bacterial growth was best achieved in pH 
6.5-7.5. Moreover, Kim et al. examined the 
effect of culture medium pH on the 
serotype 4 pneumococcal capsule 
production and showed that the capsule 
production in pH 5 to pH 8 did not enhance 
alongside the increase of bacterial growth 
[1]. In their study, the bacterial growth in 
pH 5 to pH 6 was higher than that in pH 7 
to 8. However, the capsule production in 
pH 5 to pH 6 was less than one third of that 
in pH 7 to pH 8 [1]. It is then apparent that 
selecting an appropriate pH is necessary to 
achieve high yields of the capsule 
production.The 19F capsule production by 
S. pneumoniae 82218 and its growth were 
decreased by increasing the agitation rate to 
50 rpm or higher. The serotype 4 
pneumococcal capsule production was 
inhibited by vigorous agitation (higher than 
100 rpm) but it was enhanced at
the agitation rate of 50 rpm [1]. In addition, 
the serotype 3 pneumococcal capsule 
production was decreased at agitation rates 
exceeding 180 rpm [17]. These results were 
attributed to the elevated shear stress at 
higher agitation rates and its destructive 
effects on the cells [31]. 
Using RSM for experimental designs offers 
a number of advantages including 
evaluation of factor effects, development of 
a system model as well as specifying 
optimal conditions with less experimental 
requirements [17,19]. We designed RSM 
experiments based on SFAT results. 
ANOVA of the obtained response surface 
model indicated that the capsule production 
was dependent on pH, temperature, and 
agitation rate. Moreover, the interaction 
between pH and temperature as well as the 
interaction between temperature and 
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agitation rate significantly affected the 
capsule production. The pneumococcal 
capsule production reported by other 
studies was in the range of 0.17-0.21 mg/ml 
[1, 2], whereas the optimization procedures 
used in the present study including the 
pneumococcal strain selection, optimization 
of environmental culture conditions, and 
buffering the culture medium resulted in a 
notably high level of pneumococcal capsule 
production (1.9 mg/ml). Therefore, the 
results of this study are expected to be 
applicable for the pneumococcal capsule 
production in the vaccine manufacturing 
process. 
Although buffering the culture medium 
compensates for the pH decrease, 
improving the buffering capacity through 
changing the buffer composition needs to 
be addressed in future studies. Moreover, 
designing an appropriate scale up procedure 
is an essential step towards capsule 
production for the vaccine manufacture. 
 
5. Conclusion 
     The suitable yield of capsule production 
is necessary to ensure efficient 
pneumococcal vaccine preparation. The 
present study demonstrated the importance 
of bacterial strain as well as environmental 
culture conditions for achieving the 
appropriate yield of the 19F pneumococcal 
capsule production. The capsule production 
was expressed as a quadratic model using 
environmental factors of pneumococcal 
culture. Moreover, regarding the observed 
differences in the protein electrophoretic 
profile of pneumococcal strains possessing 
different levels of capsule production, 
identification of the designated proteins can 
pave the way to construct pneumococcal 
strains with high yields of the capsule 
production through manipulations of the 
relevant genes.  
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